Searchable abstracts of presentations at key conferences in endocrinology

ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts

Published by BioScientifica

Previous issue | Volume 99 | ECE2024 | Next issue

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

We are pleased to announce that ECE 2024 will be held in Stockholm, Sweden from 11-14 May 2024. We will, once again, be offering the hybrid format next year so you can join us in person in Sweden or remotely with ECE@Home.

Poster Presentations

Pituitary and Neuroendocrinology

Previous section
Environmental Endocrinology

Table of contents

Next section
Reproductive and Developmental Endocrinology

ea0099p101 | Pituitary and Neuroendocrinology

Assessment of 24h ambulatory blood pressure in women with sheehan syndrome: prevalence of hypertension and disruption of the circadian blood pressure rhythm

ea0099p102 | Pituitary and Neuroendocrinology

Establishing BMI-Related thresholds for the 1 mg dexamethasone suppression test: a retrospective analysis

ea0099p103 | Pituitary and Neuroendocrinology

Prevalence of hypopituitarism in adults treated with intensity-modulated radiotherapy for primary, non-pituitary, brain tumours

ea0099p104 | Pituitary and Neuroendocrinology

Increment in KI-67 proliferation indices over time is associated with worse survival outcomes in small-intestinal neuroendocrine tumours

ea0099p105 | Pituitary and Neuroendocrinology

Infectious complications during cushing’s disease: about 51 cases

ea0099p106 | Pituitary and Neuroendocrinology

Diagnostic value of a 3% hypertonic saline infusion test in differential diagnosis between adh deficiency and primary polydipsia

ea0099p107 | Pituitary and Neuroendocrinology

Circulating levels of mir-375 in cushing’s disease patients and evaluation of its role in the regulation of sstr2 expression in murine pituitary corticotroph tumor cell model

ea0099p108 | Pituitary and Neuroendocrinology

Soluble α-klotho protein, nesfatin-1 and IGFBP-3 concentrations in the biochemical diagnosis and monitoring treatment effects in patients with acromegaly

ea0099p109 | Pituitary and Neuroendocrinology

Utilization of MRI in the work-up of mild hyperprolactinemia

ea0099p110 | Pituitary and Neuroendocrinology

Obesity in survivors of childhood-onset craniopharyngioma – impact of parental body mass index at craniopharyngioma diagnosis?

ea0099p326 | Pituitary and Neuroendocrinology

A randomised phase 3 trial to assess efficacy and safety of CAM2029, an octreotide subcutaneous depot, in patients with acromegaly

ea0099p112 | Pituitary and Neuroendocrinology

Metabolic syndrome in women with sheehan syndrome: prevalence and associated factors

ea0099p113 | Pituitary and Neuroendocrinology

2-[18F]FDG PET imaging biomarkers for clinical and metabolic assessment in ectopic cushing syndrome. increased spleen FDG uptake as a helpful parameter to predict the presence of metastases - a pilot study

ea0099p114 | Pituitary and Neuroendocrinology

Obesity-Related pseudo-cushing syndrome and pituitary incidentaloma: a case study

ea0099p115 | Pituitary and Neuroendocrinology

The value of digital quantification of somatostatin receptor subtypes 2 and 5 immunostaining in GH-secreting pituitary tumors

ea0099p116 | Pituitary and Neuroendocrinology

Cell lineage specific differences in clinical behavior of clinically non-functioning pituitary adenomas according to the 2017 WHO classification – a systematic review and meta-analysis

ea0099p117 | Pituitary and Neuroendocrinology

Proton beam radiotherapy for treatment of functional pituitary adenomas

ea0099p118 | Pituitary and Neuroendocrinology

Hyponatremia after COVID-19 is frequent in the first year and increases re-admissions

ea0099p119 | Pituitary and Neuroendocrinology

Management of carcinoid heart disease in neuroendocrine tumor patients: a retrospective study

ea0099p120 | Pituitary and Neuroendocrinology

Approaching the reality of restoring GH secretion and growth with the investigative oral growth hormone secretagogue (GHS) LUM-201 in moderate pediatric growth hormone deficiency (PGHD)

ea0099p121 | Pituitary and Neuroendocrinology

Adipsic diabetes insipidus - a rare complication of craniopharyngiomas

ea0099p122 | Pituitary and Neuroendocrinology

Cushing’s syndrome: normalization of cortisol is just the beginning

ea0099p123 | Pituitary and Neuroendocrinology

Longterm-outcomes in patients with cushing’s disease vs non-functioning pituitary adenoma after pituitary surgery: an active-comparator cohort study

ea0099p124 | Pituitary and Neuroendocrinology

Neuropsychological profile in acromegaly: cross sectional analysis and preliminary prospective long-term study

ea0099p125 | Pituitary and Neuroendocrinology

Consensus and controversies on the diagnosis of GH-deficiency in children and adults - A Delphi survey by the GH research society

ea0099p126 | Pituitary and Neuroendocrinology

Replace: a randomized controlled trial on the effect of hydrocortisone or placebo in patients with reported symptoms of glucocorticoid-induced adrenal insufficiency after terminating prednisolone for polymyalgia rheumatic/giant cell arteritis

ea0099p127 | Pituitary and Neuroendocrinology

Gonadotroph pituitary tumors: not always nonfunctioning

ea0099p128 | Pituitary and Neuroendocrinology

Posterior pituitary tumours: a single institutional experience of 19 patients

ea0099p129 | Pituitary and Neuroendocrinology

Usefulness of salivary cortisol in the diagnosis of adrenal insufficiency and evaluation of the hypothalamic-pituitary-adrenal axis

ea0099p130 | Pituitary and Neuroendocrinology

Paradoxical responses to pasireotide in patient with cushing’s disease

ea0099p131 | Pituitary and Neuroendocrinology

Comparative efficacy and safety of osilodrostat vs metyrapone for the treatment of Cushing’s syndrome – a matching-adjusted indirect comparison using LINC-3 and LINC-4

ea0099p132 | Pituitary and Neuroendocrinology

Is urine sαkl a potential biomarker in acromegaly?

ea0099p133 | Pituitary and Neuroendocrinology

Exploring the cardiovascular effects of recombinant human growth hormone therapy: a prospective study on endothelin-1 and asymmetric dimethyl arginine in adults with growth hormone deficiency

ea0099p134 | Pituitary and Neuroendocrinology

Macroprolactin over time: Is there any point in rechecking it in people with a persistently elevated serum prolactin?

ea0099p135 | Pituitary and Neuroendocrinology

Comprehensive clinical, transcriptomic, and functional relevance of the telomerase-shelterin system in pituitary tumors and craniopharyngiomas

ea0099p136 | Pituitary and Neuroendocrinology

Effect of oral urea on copeptin levels in healthy adults: a double-blind, randomized, placebo-controlled cross-over study

ea0099p137 | Pituitary and Neuroendocrinology

Anastrazole in the treatment of a cabergoline-resistant male prolactinoma

ea0099p138 | Pituitary and Neuroendocrinology

Challenges in the management of invasive macroprolactinomas: cranio-dural defect requiring surgery after cabergoline treatment

ea0099p139 | Pituitary and Neuroendocrinology

Pitfalls in diagnosis of the pituitary stalk lesion: infundibulo-neurohypophysitis or germ cell tumor?

ea0099p140 | Pituitary and Neuroendocrinology

Elimination of fall in glucose during glucagon stimulation test does not completely abolish an increase in growth hormone and cortisol concentrations

ea0099p312 | Pituitary and Neuroendocrinology

Maternal cortisol levels in pregnancy and intelligence quotient in children at 7 years of age. odense child cohort

ea0099p313 | Pituitary and Neuroendocrinology

TGFBR3L gene expression and relevance for the gonadotroph non-functioning pituitary neuroendocrine tumours

ea0099p314 | Pituitary and Neuroendocrinology

A complex clinical scenario: chiari type ii malformation coexisting with suprasellar paraganglioma and associated succinate dehydrogenase subunit b (SDHB) genetic mutation

ea0099p315 | Pituitary and Neuroendocrinology

Validation of baseline laboratory levels and a novel probability score in the diagnosis of patients with suspected arginine vasopressin deficiency (Central Diabetes Insipidus)

ea0099p316 | Pituitary and Neuroendocrinology

The pathogenic RET val804met variant in acromegaly: a new clinical phenotype?

ea0099p317 | Pituitary and Neuroendocrinology

Relevance of USP8 mutations in the pathogenesis of pituitary tumours of the corticotroph lineage

ea0099p318 | Pituitary and Neuroendocrinology

Circadian clock disruption impairs immune oscillation in chronic endogenous hypercortisolism: a multi-levels analysis from a multicenter clinical trial

ea0099p319 | Pituitary and Neuroendocrinology

Natural history of rathke’s cleft cysts. a retrospective analysis of a fifteen centers experience in spain

ea0099p320 | Pituitary and Neuroendocrinology

Impact of clinical and treatment characteristics on HR-QoL in patients with prolactinoma - cross-sectional analysis of a dutch multicenter prospective cohort study

ea0099p321 | Pituitary and Neuroendocrinology

Apelin and copeptin levels in patients with chronic SIAD treated with empagliflozin – a secondary analysis of the SANDx trial

ea0099p322 | Pituitary and Neuroendocrinology

Minimum data set for global monitoring of the safety and efficacy of growth hormone replacement in adults - an expert group recommendation

ea0099p323 | Pituitary and Neuroendocrinology

Predictors of corticotroph tumour recurrence after surgical resection

ea0099p324 | Pituitary and Neuroendocrinology

Drug-induced hyperprolactinemia and granulomatous mastitis: a case report and literature review

ea0099p325 | Pituitary and Neuroendocrinology

Cyclic cushing’s syndrome: a diagnostic challenge

ea0099p111 | Pituitary and Neuroendocrinology

Deciphering microenvironment interactions during age-related pituitary tumour onset and through orthotopic mouse pre-clinical model

ea0099p327 | Pituitary and Neuroendocrinology

High prevalence of vertebral fractures associated with age, GH, and bone mineral density in patients with acromegaly

ea0099p328 | Pituitary and Neuroendocrinology

Cytological, immunological and radiological predictors of the efficacy of first-generation somatostatin receptor ligands (fg-SRLs) in patients with acromegaly

ea0099p329 | Pituitary and Neuroendocrinology

Daytime sleepiness and health-related quality of life in patients with childhood-onset craniopharyngioma

ea0099p330 | Pituitary and Neuroendocrinology

A case of type 2 diabetes masked by insulinoma

ea0099p331 | Pituitary and Neuroendocrinology

Pituitary involvement in familial hemophagocytic lymphohistiocytosis type 5 associated with homozygous mutation in the syntaxin-binding protein-2 gene (STXBP2)

ea0099p332 | Pituitary and Neuroendocrinology

Sarcoma of the sphenoid sinus occurring 34 years after fractionated sellar 60Cobalt radiotherapy for acromegaly

ea0099p333 | Pituitary and Neuroendocrinology

Additive effect of combined treatment with the small peptide GH receptor antagonist, AZP-3813, and the somatostatin analog, octreotide, in decreasing IGF1 levels in the rat

ea0099p334 | Pituitary and Neuroendocrinology

Prognostic value of the pituitary apoplexy score for predicting hormonal and visual recovery of patients with pituitary apoplexy: results from a spanish multicentric study

ea0099p335 | Pituitary and Neuroendocrinology

Cardiovascular disease and gender differences in non-functioning pituitary tumors: preliminary data of a prospective study

ea0099p336 | Pituitary and Neuroendocrinology

Evaluation of new prognostic clinicopathological classification of pituitary adenomas proposed by trouillas et al. in patients with giant pituitary adenomas

ea0099p337 | Pituitary and Neuroendocrinology

Clinical and radiological predictive factors of dopamin agonist resistance in prolactinoma

ea0099p338 | Pituitary and Neuroendocrinology

Efficacy of pasireotide treatment in acromegaly: a systematic review and meta-analysis

ea0099p339 | Pituitary and Neuroendocrinology

T2-weighted MRI signal intensity of a somatotroph PitNETs-assessed with quantitative and qualitative methods- how our predictions are verified in the histopathological examination?

ea0099p340 | Pituitary and Neuroendocrinology

Improvements in diabetes and hypertension were sustained over long-term osilodrostat treatment in patients with Cushing’s disease: A pooled analysis of LINC 3 and LINC 4

ea0099p341 | Pituitary and Neuroendocrinology

A case of meningitis mimicking pituitary macroadenoma

ea0099p342 | Pituitary and Neuroendocrinology

Is histological subtyping important in the prognostication of acromegaly?

ea0099p343 | Pituitary and Neuroendocrinology

Comparative analysis of giant and ‘nearly giant’ pituitary adenomas

ea0099p344 | Pituitary and Neuroendocrinology

Growth hormone potently stimulates fibroblast activation protein activity and collagen turnover – a prospective study in newly diagnosed patients with acromegaly before and after treatment

ea0099p345 | Pituitary and Neuroendocrinology

Expression pattern of select cell proliferation and apoptotic markers in non-functioning pituitary adenomas predictive of tumour growth/recurrence: a pilot project

ea0099p346 | Pituitary and Neuroendocrinology

Incidence of nephrogenic diabetes insipidus during prolonged sevoflurane sedation in the intensive care unit: a retrospective analysis and predictive model

ea0099p347 | Pituitary and Neuroendocrinology

Safety profile of growth hormone replacement (GHr) in GH deficient patients during transition period treated for intracranial tumors and malignancy in childhood- Single center expirence

ea0099p348 | Pituitary and Neuroendocrinology

Diabetes insipidus and cerebral malaria: a rare etiology to be considered

ea0099p349 | Pituitary and Neuroendocrinology

Prolactin-related challenges in two critical moments of womens’ life: postpartum and menopause

ea0099p350 | Pituitary and Neuroendocrinology

Assessment of insulin resistance and its associated factors in women with hypopituitarism

ea0099p351 | Pituitary and Neuroendocrinology

ER stress causes variable ACTH production and secretion in corticotroph tumour cells

ea0099p510 | Pituitary and Neuroendocrinology

Plasma apelin levels in patients with polyuria-polydipsia syndrome undergoing copeptin stimulation tests

ea0099p511 | Pituitary and Neuroendocrinology

Assessment of GH/IGF1 axis in relation to pituitary volume and MRI intensity in subjects with obesity: A controlled, cross-sectional, observational study

ea0099p512 | Pituitary and Neuroendocrinology

Transsphenoidal surgical treatment of symptomatic rathke’s cysts. results, follow-up, and recurrence rates

ea0099p513 | Pituitary and Neuroendocrinology

Novel mutations causing pachydermoperiostosis - hormonal and phenotypic alterations

ea0099p514 | Pituitary and Neuroendocrinology

A Novel CDKN1B mutation in multiple endocrine neoplasia type 4

ea0099p515 | Pituitary and Neuroendocrinology

Body weight in acromegaly – does it make any difference?

ea0099p516 | Pituitary and Neuroendocrinology

Cytokeratin 18: An early biomarker of increased liver fibrosis in newly diagnosed acromegaly

ea0099p517 | Pituitary and Neuroendocrinology

Management of prolactinomas before, during and after pregnancy: results from the italian association of clinical endocrinologists (AME) survey

ea0099p518 | Pituitary and Neuroendocrinology

Long-term pharmacotherapy of giant prolactinomas

ea0099p519 | Pituitary and Neuroendocrinology

Machine learning in differential diagnosis of ACTH-dependent hypercortisolism

ea0099p520 | Pituitary and Neuroendocrinology

Use of artificial intelligence to predict survival of patients with acromegaly: is it really better?

ea0099p521 | Pituitary and Neuroendocrinology

Assessing long-term safety and efficacy of osilodrostat in prior- and new-use patients with endogenous cushing’s syndrome: a 1-year real-world interim analysis of the non-interventional, multinational LINC 6 study

ea0099p522 | Pituitary and Neuroendocrinology

Beyond idiopathic arginine vasopressin deficiency: unveiling its etiology after over a decade

ea0099p523 | Pituitary and Neuroendocrinology

Characterization of patients stopping GH therapy for childhood-onset growth hormone deficiency in belgium - luxemburg

ea0099p524 | Pituitary and Neuroendocrinology

Differences in the efficacy of second-line therapies on the biochemical control of acromegaly in patients with GH secreting pituitary neuroendocrine tumors (Pit-NETs) and GH and PRL cosecreting Pit-NETs

ea0099p525 | Pituitary and Neuroendocrinology

Pituitary apoplexy during the SARS-CoV-2 pandemic. role of acute covid-19 and covid vaccination

ea0099p526 | Pituitary and Neuroendocrinology

Epidemiology of hypothalamic obesity in craniopharyngioma and other rare sellar and suprasellar tumors

ea0099p527 | Pituitary and Neuroendocrinology

Soluble alpha klotho concentrations are resistant to short-term stimulation and suppression of growth hormone

ea0099p528 | Pituitary and Neuroendocrinology

Predictors of diabetes remission after surgery in patients with acromegaly. a series of 604 cases

ea0099p529 | Pituitary and Neuroendocrinology

A peculiar case of ectopic ACTH-syndrome – multiple challenges during diagnostic and therapeutic workup

ea0099p530 | Pituitary and Neuroendocrinology

The analgesic effect of pasireotide in aggressive, giant pituitary neuroendocrine tumors-case series

ea0099p531 | Pituitary and Neuroendocrinology

Potential antitumoral effects through modulation of VEGF-A splicing in rat somatotroph and lactotroph pituitary tumoral cells

ea0099p532 | Pituitary and Neuroendocrinology

Electronic health technologies for comprehensive acromegaly management. preliminary data from a single center experience

ea0099p533 | Pituitary and Neuroendocrinology

The relations between serum growth hormone, seminal plasma growth hormone, and sperm count in acromegaly patients

ea0099p534 | Pituitary and Neuroendocrinology

Implications of somatotroph axis in the behaviour of silent corticotroph tumours

ea0099p535 | Pituitary and Neuroendocrinology

Assessment of endothelial dysfunction in cushing`s syndrome

ea0099p536 | Pituitary and Neuroendocrinology

Prevalence of steatosis and cardio-metabolic complications in a cohort of adult patients with growth hormone deficiency: a cross-sectional study

ea0099p537 | Pituitary and Neuroendocrinology

Panhypopituitarism and diabetes mellitus in a woman with HIST1H1E syndrome

ea0099p538 | Pituitary and Neuroendocrinology

Patient with granulomatous hypophysitis in the course of granulomatosis with polyangiitis (GPA) misdiagnosed as craniopharyngioma

ea0099p539 | Pituitary and Neuroendocrinology

COVID-19 and hyponatremia: from possibility to probability

ea0099p540 | Pituitary and Neuroendocrinology

Pituitary apoplexy – a tertiary centre experience

ea0099p541 | Pituitary and Neuroendocrinology

Complications of transphenoidal surgery for non-producing pituitary adenomas are not related to pretended surgical goals or surgical experience

ea0099p542 | Pituitary and Neuroendocrinology

DXA-derived lumbar bone strain index corrected for kyphosis is associated with vertebral fractures in acromegaly

ea0099p543 | Pituitary and Neuroendocrinology

Presentation and treatment response in men with micro, macro or giant prolactinoma

ea0099p544 | Pituitary and Neuroendocrinology

A case of sporadic metastatic medullary cancer with distant metastases and negative RET mutation

ea0099p545 | Pituitary and Neuroendocrinology

Effects of recombinant growth hormone treatment on metabolic fitness, body composition and echocardiographic parameters in a population of patients with overweight or obesity and adult GH deficiency

ea0099p546 | Pituitary and Neuroendocrinology

Pregnancy in a lady with pre-existing cyclical cushing’s disease

ea0099p547 | Pituitary and Neuroendocrinology

The protean manisfestations of erdheim-chester disease

ea0099p548 | Pituitary and Neuroendocrinology

Effects of MIA-602, GHRH receptor antagonist, on emotional disorders in mice

ea0099p549 | Pituitary and Neuroendocrinology

Effects of glucagon-like peptide-1 analogs on prolactin: a randomized, double-blind, placebo-controlled crossover trial

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Biosci Abstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more